Code meets care: 20 European HealthTech startups to watch in 2025 and beyond

A new generation of HealthTech startups is emerging across Europe, redefining how we access, monitor, and manage our wellbeing. By harnessing digital solutions and software-driven technologies, these innovators are enhancing patient care, supporting medical professionals, and advancing developments in biotech and pharmaceuticals. From AI-powered diagnostics to remote monitoring and personalised treatment tools, they are shifting HealthCare from hospital walls to everyday life.

This convergence of HealthTech, biotech, and pharma is also reflected in investment trends, with combined VC funding reaching over €60 billion globally in 2024, making it the second-largest VC category after enterprise software. AI-led drug discovery stands out as a key area of focus, while digital therapeutics have become the fastest-growing HealthTech segment since 2017, according to Dealroom’s HealthTech report.

In the list below, we spotlight 20 exceptionally promising early-stage HealthTech startups from across Europe. Founded between 2022 and 2025, these startups are moving beyond traditional MedTech by developing accessible tools for prevention, remote care, and personalised wellbeing.

Adsilico: Founded in 2022, this UK-based HealthTech startup is transforming medical device development through advanced computational modelling and AI-driven simulations. By creating high-fidelity virtual patients, they enable in-silico trials that assess device safety and efficacy before human testing. These synthetic populations are customisable, scalable, and designed to reflect diverse anatomical and physiological conditions.

Their approach not only speeds up research and development timelines but also reduces the need for animal testing and lowers the risks typically associated with early-stage human trials. Backed by €4.2 million in seed funding, Adsilico’s innovative methodology is helping reshape how medical devices are brought to market—faster, safer, and with greater precision.

AERA Health: Prevention is increasingly becoming a priority in healthcare, and this Swiss startup is at the forefront of that shift. Founded in 2022 and based in Basel, AERA is reimagining how individuals manage their well-being by merging cutting-edge technology with personalised care. Its holistic platform blends predictive, participatory, and preventive medicine to help people stay ahead of potential health issues.

By integrating science, data analytics, and continuous monitoring, AERA delivers tailored health insights designed to support long-term wellness. The company’s approach has already gained traction, securing €4 million in funding to further develop its preventive health technology and empower more individuals to take control of their health.

Axithra: Headquartered in Ghent, this MedTech startup is advancing therapeutic drug monitoring with a platform that quickly and accurately measures and monitors drug concentrations in blood, enabling clinicians to tailor treatments in real time based on each patient’s specific needs.

Founded in 2023, the startup has raised €10 million to scale its solution and integrate personalised dosing into routine clinical care. By delivering actionable insights within minutes, Axithra supports faster, more precise decision-making in hospitals and other care settings.

Biorce: Focused on revolutionising the drug development process, this Barcelona-based DeepTech startup uses AI to streamline clinical research and improve access to treatments. Its flagship product, Jarvis, acts as a Clinical AI assistant that enables researchers and clinicians to instantly access and analyse clinical data, ultimately accelerating medical advancements and reducing costs.

Since its launch in 2024, Biorce have been backed by €3.5 million in funding to support its mission of making drug development faster, more efficient, and more accessible. With a clear commitment to innovation and patient outcomes, it aims to reshape how new therapies reach those who need them most.

Callyope: This Paris-based startup is redefining psychiatric care through advanced voice-based technology that helps monitor and manage mental health disorders. By analysing both the acoustic features and content of speech, its platform extracts speech biomarkers, measurable indicators that offer insights into conditions such as bipolar disorder and Huntington’s disease.

Founded in 2023, Callyope was designed for use in both clinical and remote settings, providing psychiatrists with objective tools to track patient progress and tailor treatment plans more effectively. To date, the company has raised €2.2 million to improve diagnostics, monitoring, and long-term care strategies in psychiatry.

CareLoop Health: Founded in 2022 as a spinout from the University of Manchester. CareLoop delivers digital support to patients while empowering HealthCare providers to monitor and track symptoms. This way, it bridges the gap between clinical care and everyday patient management. The platform is used alongside in-person care, offering tailored solutions for complex mental health needs. For individuals living with psychosis and schizophrenia, CareLoop can accurately predict early warning signs to help prevent relapse.

Additionally, they are involved in the realm of perinatal mental health by identifying mothers, fathers, and partners at risk of postnatal depression, enabling timely intervention by HealthCare professionals. This innovative approach to preventive health has been backed by €2.2 million in funding to further enhance its capabilities in accurately predicting future mental health problems.

Inify Laboratories: This Swedish startup is transforming cancer diagnostics by offering new pathology services powered by digital workflows and AI. With a strong focus on prostate cancer, it supports pathology labs through tools like Inify Prostate, designed to deliver fast, consistent, and accurate evaluations. The platform not only eases the workload of uropathologists but also improves diagnostic quality and turnaround times.

Based in Stockholm and founded in 2022, Inify Laboratories has raised €13.2 million to expand its high-quality diagnostic services. By partnering with HealthCare providers, it aims to deliver objective insights that support better clinical decisions and ultimately benefit patient care.

Kor: Paris-headquartered and founded in 2023, Kor is rethinking healthcare by shifting the focus from treatment to prevention. Its flagship service offers a simple three-step process to help users evaluate and improve their well-being. By collecting key health data, the app creates a personalised health profile for ongoing support.

Through the platform, users can track over 200 health markers, receive follow-up reminders, and access medical assistance when needed. Backed by €3.5 million in funding, Kor is expanding its tools to help people live longer, healthier, and more fulfilling lives.

Level Zero Health: Combining biochemistry and nanotechnology, this London-based HealthTech startup is developing advanced biosensor technology that captures clinical-grade health data outside traditional medical settings. Its devices enable HealthCare professionals, researchers, and individuals to access new types of physiological information with high precision, helping to bridge the gap between daily monitoring and clinical diagnostics.

Founded in 2023, the startup has secured €6.5 million to scale both its hardware and its subscription-based data analytics platform. To make sophisticated health data more accessible and actionable across the HealthCare ecosystem.

Neu Health: This Oxford-based digital health startup is focused on improving the care for individuals living with neurodegenerative diseases and dementia, while improving the management of chronic neurological conditions. Its app-based platform comprises a patient-facing mobile application and a clinician dashboard. Patients complete short, seven-minute assessments that track motor and cognitive function, while AI algorithms analyse the data to provide real-time insights and predict health risks. Clinicians access this information through a dedicated dashboard, enabling more informed, personalised care.

Since its launch in 2022, Neu Health has been dedicated to supporting medication adherence, education, and symptom tracking. This commitment helps patients maintain their independence and reduces the need for hospital visits. The startup is successfully backed by nearly €2 million in funding.

Nuuron: This Berlin-based neurotechnology startup is developing a non-invasive medical device designed to help people with Alzheimer’s disease regain access to their memories. By combining neuroscience, machine learning, and medical expertise, Nuuron has created a proprietary stimulation technology that targets the hippocampus, the part of the brain responsible for memory formation and recall.

Designed for home use, the device emits specific brain signals to support memory retrieval in a safe and user-friendly way. Founded in 2023, Nuuron has raised €3.5 million to advance its mission of improving quality of life through breakthrough neurostimulation.

CGC Genomics: Headquartered in Basel, this bioinformatic startup is transforming cancer care by simplifying the interpretation of complex genomic data through an explainable AI platform. Designed as a SaaS solution, the technology named QNOMX helps HealthCare providers quickly extract actionable insights from precision genomics reports, enabling faster, more personalised treatment recommendations for patients with metastatic cancer.

Launched in 2023, CGC Genomics has raised almost €2 million to help labs automate the final manual assessment of genomic profiles, shorten the time from genomic testing to treatment decisions, and improve the quality of those recommendations.

QurieGen: Launched in 2022, this Nijmegen-based startup has developed a unique AI platform capable of predicting cellular responses to drug candidate molecules, enabling a more data-driven approach to cancer drug discovery. Often referred to as the “Google Maps for cells,” the platform offers single-cell resolution insights that allow researchers to track how therapies interact with individual cells in detail. This level of granularity helps uncover mechanisms of action, avoid ineffective or toxic treatments, and accelerate the development of targeted therapies.

Its AI-powered technology is reshaping traditional cancer R&D by aligning therapeutic strategies more closely with individual patients’ biology. The startup has already raised €2.3 million and is actively collaborating with global pharmaceutical firms.

ReportAId: Founded in 2023 and based in Milan, ReportAid is a healthtech startup that leverages AI to generate medical report data. Its platform delivers structured, AI-driven outputs that support clinical workflows and enhance communication across care teams. By drawing from extensive health data sources, ReportAid simplifies and accelerates the reporting process.

The startup has expanded its services within the Italian health system, partly due to successfully securing €2.2 million in funding. Its technology increases reporting speed and consistency without compromising accuracy.

roclub: This Berlin-based startup offers a remote control platform for operating medical imaging equipment, such as MRI and CT scanners. With its system, radiographers can carry out scans from a distance, regardless of the scanner’s brand or location. The technology is plug-and-play, requiring only a monitor and keyboard connection. It’s designed to help hospitals and clinics deal with staff shortages, reduce operational costs, and offer diagnostic imaging services in places where specialists aren’t physically available.

Founded in 2022, roclub has raised €6 million to expand its platform and services. Additionally, the startup also runs a marketplace where hospitals can book external radiographers and includes a referral and bonus programme to incentivise adoption.

Ryver: Founded in 2022 and based in Munich, Ryver is helping medical teams tackle a critical challenge in healthcare innovation: access to diverse and high-quality radiology data. The startup’s software uses generative AI to create synthetic medical images, reducing bias in training datasets while dramatically cutting down the time and cost needed for data acquisition and annotation.

Its platform can produce annotated images in minutes, with pixel-level precision and dedicated support for underrepresented patient groups. Backed with €1.3 million in funding, Ryver is offering a faster, more cost-effective way for teams to test and train diagnostic algorithms with greater accuracy and inclusivity.

SOULA: This Limassol-based digital health startup offers an AI-powered wellbeing assistant designed to support women through pregnancy, childbirth, and the postpartum period. The app combines a smart chatbot, personalised content, and a pregnancy tracker to provide round-the-clock educational and emotional support. By addressing common concerns and mental health challenges, it aims to reduce postpartum depression and foster stronger family bonds.

Founded in 2022, the startup has raised €1.25 million to continue developing an empathetic AI to support female wellbeing.

Steto: It is developing digital therapies and remote monitoring solutions to support people living with diabetes. Steto’s platform enables endocrinologists to collaborate with diabetes-specialised nurses, who provide ongoing remote support to patients between clinic visits. From device training to insulin management, Steto helps patients better implement their treatment plans and stay engaged in their care.

Founded in 2022 and headquartered in Paris, Steto is backed with €1.2 million to expand its remote patient monitoring platform. By combining medical expertise with digital tools, Steto aims to improve long-term outcomes for diabetes patients while reducing the burden on HealthCare systems.

Tandem Health: Minimising administrative burden in HealthCare, Tandem Health uses advanced AI to assist clinicians with real-time medical note-taking during patient consultations. By allowing medical providers to verbalise findings that are automatically transcribed and structured, the tool streamlines documentation without interrupting the clinical workflow. It also increases patient involvement by keeping the consultation more conversational and focused.

Founded in 2023 and based in Stockholm, the startup has raised €8.4 million. Tandem Health’s solution is designed to be intuitive, requiring minimal setup, and is compatible with various consultation settings, including in-person, video, and phone consultations.

theblood: Focused on menstrual health, this Berlin-based startup has developed a non-invasive testing kit called Cycle-Check, designed to give women personalised insights into their hormonal and overall well-being using menstrual blood. By applying advanced data analysis to a typically overlooked biological sample, the startup helps users better understand their cycles, manage discomfort, and make informed health decisions.

Founded in 2022, theblood secured €1.2 million in investment to support its growth. With an expanding user base, the startup aims to unlock the potential of menstrual blood to provide groundbreaking insights into period pain, endometrial-related disorders, and overall well-being

By the way: If you’re a corporate or investor looking for exciting startups in a specific market for a potential investment or acquisition, check out our Startup Sourcing Service! Also, if you are interested in HealthTech, also check out our HealthHack newsletter. 

The post Code meets care: 20 European HealthTech startups to watch in 2025 and beyond appeared first on EU-Startups.